A 38-year-old woman with a 3-year history of treated hypothyroidism (on levothyroxine 75 μg daily) presents with persistent fatigue, weight gain, and muscle aches despite reported compliance with medication. Her TSH is 6.2 mIU/L and free T4 is 1.1 ng/dL (both within or near-normal range). Serum ferritin is 8 ng/mL (normal 12–150), hemoglobin 10.2 g/dL, and celiac serology (tissue transglutaminase IgA) is positive. What is the most likely explanation for her persistent symptoms despite apparent adequate levothyroxine dosing?

Explanation

## Diagnosis: Malabsorption-Induced Levothyroxine Deficiency in Celiac Disease ### Clinical Context **Key Point:** This patient has celiac disease (positive tissue transglutaminase IgA) with villous atrophy, which severely impairs intestinal absorption of levothyroxine. Despite adequate dosing and compliance, the drug does not reach therapeutic levels. **High-Yield:** Celiac disease is the most common cause of levothyroxine malabsorption in hypothyroid patients. It is also strongly associated with autoimmune thyroid disease (Hashimoto thyroiditis)—both are autoimmune conditions with shared genetic predisposition. ### Why Symptoms Persist Despite "Adequate" TSH/T4 Levels **Clinical Pearl:** The TSH and free T4 values are misleading in this context: - TSH 6.2 mIU/L is *elevated* (normal <4.0), indicating inadequate thyroid hormone effect - Free T4 1.1 ng/dL is at the *lower end* of normal - The patient remains biochemically hypothyroid despite the levothyroxine prescription The reason: **malabsorption** means the levothyroxine dose is being lost in the GI tract before absorption. The TSH and T4 reflect the *actual* bioavailable hormone, not the prescribed dose. ### Supporting Laboratory Evidence | Finding | Significance | |---------|-------------| | Positive tissue transglutaminase IgA | Confirms celiac disease; indicates active intestinal inflammation | | Low ferritin (8 ng/mL) | Iron deficiency common in celiac disease due to villous atrophy | | Hemoglobin 10.2 g/dL | Mild anemia, consistent with iron malabsorption | | TSH 6.2 mIU/L | Elevated; patient is biochemically hypothyroid | | Free T4 1.1 ng/dL | Low-normal; insufficient thyroid hormone bioavailability | **Key Point:** The combination of celiac serology positivity + iron deficiency + inadequate TSH suppression despite levothyroxine = **malabsorption syndrome**. ### Pathophysiology of Malabsorption in Celiac Disease 1. Gluten ingestion → immune-mediated villous atrophy in small intestine 2. Loss of absorptive surface area → reduced absorption of levothyroxine (and iron, B12, fat-soluble vitamins) 3. Levothyroxine is absorbed primarily in the proximal small intestine; villous damage here is particularly damaging 4. Inadequate levothyroxine bioavailability → persistent hypothyroid symptoms despite prescription ### Management Strategy **Clinical Pearl:** The solution is **not** to increase levothyroxine dose blindly. Instead: 1. **Confirm celiac disease** with upper endoscopy and duodenal biopsy (if not already done) 2. **Initiate strict gluten-free diet** → intestinal healing over weeks to months 3. **Monitor TSH and free T4** at 6–8 weeks after dietary compliance; as villous function recovers, levothyroxine absorption improves 4. **Gradually reduce levothyroxine dose** as absorption improves (to avoid over-replacement) 5. **Supplement iron** (ferritin 8 is deficient) to optimize overall absorption and energy **Mnemonic:** **MALABSORPTION in Celiac = Levothyroxine Loss** - M: Malabsorption syndrome - A: Autoimmune (celiac + Hashimoto often coexist) - L: Levothyroxine bioavailability reduced - A: Absorption in proximal small intestine impaired - B: Biopsy confirms villous atrophy ### Why This Is High-Yield for NEET PG Celiac disease is increasingly recognized as a cause of "treatment-resistant" hypothyroidism. Examiners test the concept that TSH/T4 values alone do not tell the whole story—clinical context (malabsorption signs: iron deficiency, positive celiac serology) is essential. [cite:Harrison 21e Ch 405, Ch 351]